AAV therapies by convection enhanced delivery (CED): What to expect from non-clinical safety studies

被引：0
|
作者：
Vats, Srishti [1 ]
Bouchard, Amelie [1 ]
Foret, Morgan [1 ]
Maghezzi, Said [1 ]
Galicia, Archival [1 ]
Bennamoune, Nehla [1 ]
Authier, Simon [1 ]
机构：
[1] Charles River Labs, Laval, PQ, Canada
来源：
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS | 2023年 / 123卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
SP028
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Safety Implications of Modulating Nuclear Receptors: A Comprehensive Analysis from Non-Clinical and Clinical Perspectives
    Rao, Mohan
    Mcduffie, Eric
    Srivastava, Sanjay
    Plaisted, Warren
    Sachs, Clifford
    PHARMACEUTICALS, 2024, 17 (07)
  • [22] Tissue distribution and abuse potential of prucalopride: findings from non-clinical and clinical studies
    Derakhchan, Katayoun
    Lou, Zhen
    Wang, Hong
    Baughman, Robert
    DRUGS IN CONTEXT, 2023, 12
  • [23] CLINICAL EFFICACY OF MDNA55, AN INTERLEUKIN-4 RECEPTOR TARGETED IMMUNOTHERAPY, IN RECURRENT GBM DELIVERED BY CONVECTION ENHANCED DELIVERY (CED)
    Sampson, John
    Achrol, Achal
    Aghi, Manish
    Bankiewiecz, Krystof
    Bexon, Martin
    Brem, Steven
    Brenner, Andrew
    Chandhasin, Chandtip
    Chowdhary, Sajeel
    Coello, Melissa
    Ellingson, Benjamin
    Floyd, John
    Han, Seunggu
    Kesari, Santosh
    Merchant, Fahar
    Merchant, Nina
    Randazzo, Dina
    Vogelbaum, Michael
    Vrionis, Frank
    Zabek, Miroslaw
    Butowski, Nicholas
    NEURO-ONCOLOGY, 2020, 22 : 35 - 35
  • [24] Arrhythmogenic liability screening in cardiovascular safety pharmacology: Commonality between non-clinical safety pharmacology and clinical thorough QT (TQT) studies
    Authier, Simon
    Pugsley, Michael K.
    Troncy, Eric
    Curtis, Michael J.
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2010, 62 (02) : 83 - 88
  • [25] Safety and clinical findings 12-months following bilateral putaminal convection enhanced delivery of AAV2-GDNF in early and moderate stages of Parkinson's Disease
    Van Laar, A. D.
    Christine, C. W.
    Merlola, A.
    Phielipp, N. M.
    Elder, J. B.
    Larson, P. S.
    Stoicea, N.
    Sebastian, W. San
    Fiandaca, M. S.
    Kells, A. P.
    Bankiewicz, K. S.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A70 - A71
  • [26] An overview of non-clinical safety studies in current Turkish regulations for the development of COVID-19 vaccines
    Ozdem, Sadi S.
    BIOLOGICALS, 2022, 75 : 1 - 2
  • [27] The Melius project: A Spanish industrial project to improve the translational prediction of the non-clinical safety studies to man
    Vericat, J. A.
    Aviles, P.
    Castro, A.
    Eibe, C.
    Fernandez, D.
    Guardia, M.
    Ledo, F.
    Osaba, L.
    Rey, M.
    TOXICOLOGY LETTERS, 2010, 196 : S266 - S266
  • [28] Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia
    Lidonnici, Maria Rosa
    Paleari, Ylenia
    Tiboni, Francesca
    Mandelli, Giacomo
    Rossi, Claudia
    Vezzoli, Michela
    Aprile, Annamaria
    Lederer, Carsten Werner
    Ambrosi, Alessandro
    Chanut, Franck
    Sanvito, Francesca
    Calabria, Andrea
    Poletti, Valentina
    Mavilio, Fulvio
    Montini, Eugenio
    Naldini, Luigi
    Cristofori, Patrizia
    Ferrari, Giuliana
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2018, 11 : 9 - 28
  • [29] Translational knowledge in minipigs: a way forward to reduce the use of nonhuman primates in non-clinical safety studies
    van Cruchten, S.
    TOXICOLOGY LETTERS, 2023, 384 : S3 - S3
  • [30] Safety and Tolerability of Magnetic Resonance Imaging-Guided Convection-Enhanced Delivery of AAV2-hAADC with a Novel Delivery Platform in Nonhuman Primate Striatum
    San Sebastian, Waldy
    Richardson, R. Mark
    Kells, Adrian P.
    Lamarre, Clementine
    Bringas, John
    Pivirotto, Philip
    Salegio, Ernesto A.
    DeArmond, Stephen J.
    Forsayeth, John
    Bankiewicz, Krystof S.
    HUMAN GENE THERAPY, 2012, 23 (02) : 210 - 217
12345